LabCorp

Teal Health is dedicated to improving women's health by providing at-home cervical cancer screenings. The company has developed an FDA-approved device that allows women to perform these essential screenings in the comfort and privacy of their own homes. By simplifying the process, Teal Health aims to encourage timely screenings, which are crucial for early detection and treatment, ultimately striving to eradicate cervical cancer in the United States. The initiative is supported by a group of committed investors who share the vision of transforming women's health experiences.

PreciseDx is a company specializing in cancer risk stratification by providing patient-specific risk assessments through the analysis of morphological features. Utilizing artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that offer detailed insights into each patient's risk profile and potential outcomes, thereby enhancing treatment decision-making. The company combines its clinical, regulatory, and translational research expertise to advance technologies in areas such as clinical modeling, patient phenotyping, and image analysis, ultimately aiming to improve patient outcomes and quality of life in the realm of cancer and other diseases.

NOWDiagnostics, Inc. is a company based in Springdale, Arkansas, that specializes in the development and manufacturing of blood-based rapid diagnostic tests. Founded in 2013, the company offers innovative testing solutions that require only a single drop of blood, providing results within minutes. This approach empowers both patients and caregivers by enabling timely decision-making regarding healthcare. NOWDiagnostics' product line, ADEXUSDx, includes tests for various conditions such as pregnancy, cardiac events, and toxicology, all designed to be conducted in-home or in-clinic without the need for off-site laboratory processing. The company aims to reduce the waiting time for test results, enhancing the overall efficiency of medical diagnostics. NOWDiagnostics collaborates with strategic partners, including Zalgen Labs LLC, to expand its offerings in the diagnostic market.

Phenomix Sciences is a biotechnology company founded in 2017 and headquartered in New York, United States. It specializes in the fields of metabolomics and genomics, focusing on developing healthcare solutions for personalized management of chronic diseases. The company has created a data analysis platform aimed at precision medicinal research for obesity management, which features a novel blood test and an AI-driven algorithm. This platform classifies the unique pathophysiological phenotype of patients with obesity, providing healthcare centers with tools and services that enhance the efficacy of obesity management while also reducing side effects and overall costs.

Evvy is a company focused on improving female health by offering at-home vaginal microbiome tests. These tests utilize metagenomic sequencing to analyze symptoms and identify risks associated with important health issues. By providing personalized reports, Evvy aims to empower women with insights about their bodies, thereby addressing the gender health gap and enhancing overall health outcomes for women.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Ovia Health is a digital healthcare company that provides a comprehensive maternity and family benefits solution aimed at supporting women and families throughout the parenthood journey. Formerly known as Ovuline, the company offers a suite of mobile applications, including Ovia Fertility and Ovia Pregnancy, which deliver personalized information and resources related to fertility, pregnancy, and parenting. By empowering women with customized health insights, Ovia Health enables them to take control of their reproductive health and start families with confidence, ultimately transforming healthcare into a lifestyle choice.

Weavr Health is transforming blood collection by enabling patients to collect clinical-grade blood samples in their own homes without the need for a phlebotomist. The company has developed a self-collection device that allows average users to perform complex sample processing steps without requiring trained professionals or specialized laboratory equipment. This innovation simplifies the diagnostic testing process, making it more efficient and accessible at the point of care. By focusing on user-friendly solutions, Weavr Health aims to enhance the healthcare experience and streamline blood collection procedures.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Vivify Health Inc. operates a cloud-based, device-agnostic software platform that facilitates home-based remote monitoring, connecting healthcare providers with patients through consumer electronics. This platform aims to reduce hospital readmissions and associated healthcare costs by enabling virtual interactions between patients and doctors. Vivify Health offers various personal health devices, including tablets, weight scales, and pulse oximeters, to support its remote care management solutions. Founded in 2009 and based in Plano, Texas, the company was formerly known as Intuitive Health, Inc. and rebranded in May 2013. Vivify Health operates as a subsidiary of Optum, Inc., following a transaction announced in December 2019. Through its technology, the company seeks to enhance population health, optimize patient engagement, and improve overall patient satisfaction while facilitating the expansion of physician practice services.

LipoScience, based in Raleigh, North Carolina, specializes in developing in vitro diagnostic tests utilizing nuclear magnetic resonance (NMR) technology. The company's flagship product, the NMR LipoProfile test, quantifies low density lipoprotein particles (LDL-P) in blood samples, offering crucial insights for physicians and patients to tailor heart disease risk management. With more than 8 million tests ordered, LipoScience is at the forefront of personalized diagnostics, providing actionable data that enhances patient care and treatment strategies.

DCL Medical Laboratories, Inc. provides a range of laboratory testing solutions, specializing in anatomic and molecular pathology services. The company offers diagnostic cytopathology and histopathology, as well as immunohistochemistry services that include a variety of antibodies for biomarker analysis and customized methodologies for processing biopsy specimens. DCL Medical Laboratories also supports clinical trials and delivers reference testing focused on women's health, including ThinPrep Pap test processing, HPV molecular testing, and screening for chlamydia, gonorrhea, and cystic fibrosis carriers. Serving the medical industry across the United States, DCL Medical Laboratories aims to enhance diagnostic accuracy and patient care through its comprehensive testing services.

Outcomes4Me Inc. is an AI-driven healthcare platform based in Cambridge, Massachusetts, founded in 2017. It focuses on empowering cancer patients by providing access to personalized, evidence-based treatment options and clinical information. The platform enables patients to navigate their care proactively, facilitating informed decision-making and improving health outcomes. By democratizing healthcare, Outcomes4Me promotes health equity and supports deeper insights into patient care, while also accelerating research and access to innovative treatments. The company is led by a team of experienced professionals from various sectors, including healthcare, oncology, and technology, dedicated to enhancing the patient experience in cancer treatment.